AI and ML in Migraine Treatment: Predicting Drug Response

Research Summary

A new study in Pharmacotherapy highlights the potential of artificial intelligence (AI) and machine learning (ML) to transform migraine treatment by predicting individual responses to medications. This scoping review analyzed 12 studies using AI/ML models to forecast responses to acute and preventive migraine therapies, such as anti-calcitonin gene-related peptide monoclonal antibodies and nonsteroidal anti-inflammatory drugs. While these models showed high predictive accuracy, their clinical application is hindered by methodological issues, including over-reliance on internal validation and lack of genetic data. The study emphasizes the need for external validation and diverse data to advance personalized migraine treatment effectively.

Study Details

📄 Title: Predicting Pharmacological Treatment Response in Migraine Using AI/ML: A Scoping Review of the Evidence and Future Directions.

👥 Research Team: Giacon M, Terrazzino S

📚 Published In: Pharmacotherapy

📅 Publication Date: 2025 Nov 23

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.